JKJatinder Kaur

Jatinder Kaur

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jatinder Kaur has a total of 98 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Optimization of a Pyrimidinone Series for Selective Inhibition of Ca2+/Calmodulin-Stimulated Adenylyl Cyclase 1 Activity for the Treatment of Chronic Pain

    by Jason A. Scott, Monica Soto-Velasquez, Michael P. Hayes, Justin E. LaVigne, Heath R. Miller, Jatinder Kaur, Karin F. K. Ejendal, Val J. Watts, Daniel P. Flaherty

    Adenylyl cyclase type 1 (AC1) is involved in signaling for chronic pain sensitization in the central nervous system and is an emerging target for the treatment of chronic pain. AC1 and a closely related isoform AC8 are also implicated to have roles in learning and memory signaling processes. Our team has carried out cellular screening for inhibitors of AC1 yielding a pyrazolyl-pyrimidinone scaffold with low micromolar potency against AC1 and selectivity versus AC8. Structure–activity relationship (SAR) studies led to analogues with cellular IC50 values as low as 0.25 μM, selectivity versus AC8 and other AC isoforms as well as other common neurological targets. A representative analogue displayed modest antiallodynic effects in a mouse model of inflammatory pain. This series represents the most potent and selective inhibitors of Ca2+/calmodulin-stimulated AC1 activity to date with improved drug-like physicochemical properties making them potential lead compounds for the treatment of inflammatory pain.


  • Open Access

    Projected changes in temperature and rainfall during 21st century simulated by CSIRO-Mk-3-6-0 model under RCP based scenarios in Punjab

    by Jatinder Kaur, Prabhjyot Kaur, Samanpreet Kaur

    A study was conducted to assess the projected changes in climatic parameters during 21st century in Punjab state. The CSIRO-Mk 3-6-0 model simulated data was downscaled from the website http://gismap.ciat.cgiar.org/MarkSimGCM/ for seven locations under four RCP scenarios. The two future periods, i.e., mid-century (MC: 2020-2049) and end-century (EC: 2066-2095) were assessed on annual and seasonal (kharif and rabi) basis. During mid-century the annual, kharif and rabi seasons maximum temperature is projected to increase from baseline period between 0 to 1.5 °C, 0.3 to 1.5 °C and 0 to 1.6 °C, respectively; minimum temperature to increase from baseline period between 1.1 to 3.1 °C, 0.1 to 4.8 °C and 0.3 to 1.8 °C, respectively but the rainfall to decrease from baseline period between 33 to 554 mm, 20 to 443 mm and 20 to 110 mm, respectively. During the end-century the annual, kharif and rabi seasons maximum temperature is projected to increase from baseline period between 0.8 to 4.4°C, 0.8 to 4.3 °C and 0.6 to 4.9 °C, respectively; minimum temperature to increase from baseline period between 0.4 to 6.6 °C, 0.5 to 6.3 °C and 0.0 to 5.5 °C, respectively but the rainfall to decrease from baseline period between 3 to 610 mm, 14 to 506 mm and 17 to 107 mm, respectively. Rainfall was projected to increase at Abohar (11-41 mm) while it may decline at Amritsar (49-128 mm), Ballowal Saunkhri (501-554 mm), Ludhiana (131-152 mm), Patiala (148-187), Bathinda (49-82 mm) and Faridkot (33-67 mm).


  • Effects of thickness on the wettability and electrical properties of Sn thin films

    by Jatinder Kaur, Ravish K. Jain, Atul Khanna, Amit K. Chawla

    Sn films of four thicknesses, 50, 200, 500, and 1000 nm, were deposited on Si (111) substrates by a thermal evaporation technique, and the effects of thickness on the structural, surface morphology, electrical, and wettability properties were investigated. X-ray diffraction studies revealed the coexistence of predominantly β-Sn (metallic phase) and small concentration of α-Sn (semiconducting phase) in all samples except the 1000 nm thickness sample which is entirely β-Sn. The crystallite size and surface roughness enhance with thickness, and the 1000 nm film shows secondary nucleation growth which lowers the average crystallite size and the surface roughness of the sample. The 50 nm film shows semiconducting electrical properties while all other samples are metallic. The wettability studies found that Sn films are hydrophobic with a maximum water contact angle of 128° for the 1000 nm sample. It is concluded that the thickness critically determines the phase formation, surface topography, electrical properties, and hydrophobic properties of Sn films.


  • Structure–Activity Relationship Studies of Acetazolamide-Based Carbonic Anhydrase Inhibitors with Activity against Neisseria gonorrhoeae

    by Chad S. Hewitt, Nader S. Abutaleb, Ahmed E. M. Elhassanny, Alessio Nocentini, Xufeng Cao, Devon P. Amos, Molly S. Youse, Katrina J. Holly, Anil Kumar Marapaka, Weiwei An, et al.

    Neisseria gonorrhoeae is an urgent threat to public health in the United States and around the world. Many of the current classes of antibiotics to treat N. gonorrhoeae infection are quickly becoming obsolete due to increased rates of resistance. Thus, there is a critical need for alternative antimicrobial targets and new chemical entities. Our team has repurposed the FDA-approved carbonic anhydrase inhibitor scaffold of acetazolamide to target N. gonorrhoeae and the bacteria’s essential carbonic anhydrase, NgCA. This study established both structure–activity and structure–property relationships that contribute to both antimicrobial activity and NgCA activity. This ultimately led to molecules 20 and 23, which displayed minimum inhibitory concentration values as low as 0.25 μg/mL equating to an 8- to 16-fold improvement in antigonococcal activity compared to acetazolamide. These analogues were determined to be bacteriostatic against the pathogen and likely on-target against NgCA. Additionally, they did not exhibit any detrimental effects in cellular toxicity assays against both a human endocervical (End1/E6E7) cell line or colorectal adenocarcinoma cell line (Caco-2) at concentrations up to 128 μg/mL. Taken together, this study presents a class of antigonococcal agents with the potential to be advanced for further evaluation in N. gonorrhoeae infection models.


  • Optimization of Acetazolamide-Based Scaffold as Potent Inhibitors of Vancomycin-Resistant Enterococcus

    by Jatinder Kaur, Xufeng Cao, Nader S. Abutaleb, Ahmed Elkashif, Amanda L. Graboski, Aaron D. Krabill, Ahmed Hassan AbdelKhalek, Weiwei An, Atul Bhardwaj, Mohamed N. Seleem, et al.

    Vancomycin-resistant enterococci (VRE) are the second leading cause of hospital-acquired infections (HAIs) attributed to a drug-resistant bacterium in the United States, and resistance to the frontline treatments is well documented. To combat VRE, we have repurposed the FDA-approved carbonic anhydrase drug acetazolamide to design potent antienterococcal agents. Through structure–activity relationship optimization we have arrived at two leads possessing improved potency against clinical VRE strains from MIC = 2 μg/mL (acetazolamide) to MIC = 0.007 μg/mL (22) and 1 μg/mL (26). Physicochemical properties were modified to design leads that have either high oral bioavailability to treat systemic infections or low intestinal permeability to treat VRE infections in the gastrointestinal tract. Our data suggest the intracellular targets for the molecules are putative α-carbonic and γ-carbonic anhydrases, and homology modeling and molecular dynamics simulations were performed. Together, this study presents potential anti-VRE therapeutic options to provide alternatives for problematic VRE infections.


  • Optimization of a 1,3,4-oxadiazole series for inhibition of Ca2+/calmodulin-stimulated activity of adenylyl cyclases 1 and 8 for the treatment of chronic pain

    by Jatinder Kaur, Monica Soto-Velasquez, Zhong Ding, Ahmadreza Ghanbarpour, Markus A. Lill, Richard M. van Rijn, Val J. Watts, Daniel P. Flaherty


  • Glutathione S-Transferase π-Activatable O2-(Sulfonylethyl Derived) Diazeniumdiolates Potently Suppress Melanoma in Vitro and in Vivo

    by Zhangjian Huang, Jianbing Wu, Yu Zou, Haoliang Yuan, Yinqiu Zhang, Yue Fei, Atul Bhardwaj, Jatinder Kaur, Edward E. Knaus, Yihua Zhang

    A group of glutathione S-transferase π (GSTπ)-activatable O2-(sulfonylethyl derived)diazeniumdiolates 5-12 were designed and synthesized. These compounds could be activated by GSTπ to initiate the β-elimination reaction, liberating an active vinyl sulfone-based GSH derivative and a diazeniumdiolate anion which subsequently releases NO in situ. The most active compound 6 released relatively high levels of NO and inhibited proliferation of melanoma B16 cells, superior to a diazeniumdiolate-based anticancer agent JS-K (1). Importantly, 6 had 8-fold less inhibitory activity against normal epithelial JB6 Cl 30-7b cells. The inhibitory activity of 6 could be diminished by an NO scavenger or GSTπ inhibitor. Furthermore, 6 induced nitration of mitochondrial tyrosine in B16 cells and inoculated B16 tumors in mice, which might be responsible for oxidation of protein leading to tumor suppression. Finally, 6 significantly retarded the B16 cells growth in a mouse xenograft model. These findings suggest that 6 may have a potential to treat melanoma.


  • Ruthenium(II) complexes of aroylhydrazones: structural, electrochemical and electrostatic interactions with DNA

    by Jatinder Kaur, Madhura Damle, Hemant Mande, Prasanna Ghalsasi, Rajendra Kondedeshmukh, Parbati Bandyopadhyay, Rajeev Chikate


  • Fluorescent Hexose Conjugates Establish Stringent Stereochemical Requirement by GLUT5 for Recognition and Transport of Monosaccharides

    by Olivier-Mohamad Soueidan, Thomas W. Scully, Jatinder Kaur, Rashmi Panigrahi, Alexandr Belovodskiy, Victor Do, Carson D. Matier, M. Joanne Lemieux, Frank Wuest, Chris Cheeseman, et al.

    The specificity characteristics of transporters can be exploited for the development of novel diagnostic therapeutic probes. The facilitated hexose transporter family (GLUTs) has a distinct set of preferences for monosaccharide substrates, and while some are expressed ubiquitously (e.g., GLUT1), others are quite tissue specific (e.g., GLUT5, which is overexpressed in some breast cancer tissues). While these differences have enabled the development of new molecular probes based upon hexose- and tissue-selective uptake, substrate design for compounds targeting these GLUT transporters has been encumbered by a limited understanding of the molecular interactions at play in hexose binding and transport. Four new fluorescently labeled hexose derivatives have been prepared, and their transport characteristics were examined in two breast cancer cell lines expressing mainly GLUTs 1, 2, and 5. Our results demonstrate, for the first time, a stringent stereochemical requirement for recognition and transport by GLUT5. 6-NBDF, in which all substituents are in the d-fructose configuration, is taken up rapidly into both cell lines via GLUT5. On the other hand, inversion of a single stereocenter at C-3 (6-NBDP), C-4 (6-NBDT), or C-5 (6-NDBS) results in selective transport via GLUT1. An in silico docking study employing the recently published GLUT5 crystal structure confirms this stereochemical dependence. This work provides insight into hexose-GLUT interactions at the molecular level and will facilitate structure-based design of novel substrates targeting individual members of the GLUT family and forms the basis of new cancer imaging or therapeutic agents.